A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex

Condition:   Tuberous Sclerosis Complex Associated Neuropsychiatric Disease Intervention:   Drug: Cannabidiol Oral Solution [Epidiolex] Sponsor:   Jazz Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials